Cover Image

2020 MHC Awards and Recognition

Saved in:

Bibliographic Details
Main Authors:	Amy VandenBerg, PharmD, BCPP (Author), Erica A. K. Davis, PharmD, BCPS, BCPP (Author)
Format:	Book
Published:	American Association of Psychiatric Pharmacists, 2021-05-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

2023 MHC Awards and Recognition
by: Amy VandenBerg, PharmD, BCPP, et al.
Published: (2024)

2022 MHC Awards and Recognition
by: Erica A. K. Davis, PharmD, BCPS, BCPP, et al.
Published: (2023)

2021 MHC Awards and Recognition
by: Amy VandenBerg, PharmD, BCPP, et al.
Published: (2022)

Response to comment on the recently published article "An update on recently approved long-acting injectable second-generation antipsychotics: Knowns and unknowns regarding their use"
by: VandenBerg Amy M. PharmD, BCPP
Published: (2023)

An update on recently approved long-acting injectable second-generation antipsychotics: Knowns and unknowns regarding their use
by: Amy M. VandenBerg, PharmD, BCPP
Published: (2022)

Retracing our steps to understand ketamine in depression: A focused review of hypothesized mechanisms of action
by: Madison N. Irwin, PharmD, et al.
Published: (2021)

Vertigoheel induced psychosis: A patient case report
by: Megan O'Connell, PharmD, BCPP, et al.
Published: (2021)

Loxapine in patient with clozapine-resistant psychosis
by: Jennifer Erley, PharmD, MBA, BCPS, et al.
Published: (2021)

Differences in serum concentration with valproate oral solution versus delayed-release divalproex in an adherent patient
by: Davis Erica A. K. PharmD, BCPS, BCPP
Published: (2023)

Impact on hospital-wide antipsychotic prescribing practices through physician peer comparison letters
by: Erica A. K. Davis, PharmD, BCPS, BCPP
Published: (2022)

Characterization of inpatient care for patients admitted to a psychiatric hospital with a home opioid prescription
by: Kei Takamura, PharmD, BCPS, BCPP, et al.
Published: (2023)

Impact of a pharmacist-driven tardive dyskinesia screening service
by: Niyati Butala, PharmD, BCPP, et al.
Published: (2021)

Impact of Board Certified Psychiatric Pharmacists on improving urinary tract infection antibiotic appropriateness at an acute psychiatric hospital
by: Hamad Mohammad Adam PharmD, BCPS, et al.
Published: (2023)

Risperidone-induced angioedema
by: Caitlin Burton, PharmD, BCPP, et al.
Published: (2024)

Probable haloperidol decanoate-induced fever in an African American with benign ethnic neutropenia: A case report
by: Lara Youniss, BS, BA, et al.
Published: (2021)

Best practice model for outpatient psychiatric pharmacy practice, part 1: Development of initial attribute statements
by: Richard J. Silvia, PharmD, BCPP, et al.
Published: (2022)

Exploring the harm reduction paradigm: the role of Board-Certified Psychiatric Pharmacists
by: Amber R. Douglass, PharmD, BCPS, BCPP, et al.
Published: (2024)

Opioid antagonists to prevent olanzapine-induced weight gain: A systematic review
by: S. Andrea Laguado, PharmD, BCPS, BCPP, et al.
Published: (2023)

A Veterans Affairs' perspective in response to Best Practice Model Subcommittee attribute statements for outpatient psychiatric pharmacists
by: Jonathan F. Lister, PharmD, BCPP, et al.
Published: (2022)

Systematic literature review of the impact of psychiatric pharmacists
by: Jessica L. Ho, PharmD, BCPP, BCPS, et al.
Published: (2024)

Survey of noncontrolled medication misuse patterns
by: Amelia Slane, PharmD, et al.
Published: (2022)

COVID-19 reinfection in a patient with a serious mental illness within a long-term inpatient psychiatric care hospital
by: Brianna Englett, PharmD, BCPP, et al.
Published: (2021)

Effect of cannabis use on PTSD treatment outcomes in veterans
by: Meagan Petersen, PharmD, BCPP, et al.
Published: (2021)

Assessment of oral overlap with antipsychotic long-acting injectables initiated in an inpatient setting
by: Tran Jennifer T. PharmD, et al.
Published: (2023)

Development and implementation of a physician-pharmacist collaborative practice model for provision and management of buprenorphine/naloxone
by: Lindsay M. Mailloux, PharmD, et al.
Published: (2021)

Positioning psychiatric pharmacists to improve mental health care
by: Julie A. Dopheide, PharmD, BCPP, FASHP, et al.
Published: (2022)

Intranasal esketamine use in bipolar disorder: A case report
by: Courtney Skriptshak, PharmD, et al.
Published: (2021)

Comparison of intramuscular haloperidol and other short-acting injectable antipsychotics for management of acute agitation in an adult inpatient psychiatry unit
by: Sarah Gamcsik, PharmD, et al.
Published: (2024)

The clinical utility of newer antidepressant agents: Understanding the role in management of MDD
by: Kristin Waters, PharmD, BCPS, BCPP
Published: (2022)

Publication rates and characteristics of PGY2 psychiatric pharmacy resident research projects
by: Dayton L. Antley, PharmD, BCPS, BCPP, et al.
Published: (2023)

Addition of a clinical pharmacist practitioner to an inpatient addiction triage team and related medication outcomes
by: Kim Ehrhard, PharmD, BCPP, et al.
Published: (2023)

Pharmacokinetic and pharmacodynamic considerations with psychiatric disorders and migraines
by: Emma C. Palmer, PharmD, BCPS, BCPP, et al.
Published: (2024)

Comparison of long-acting injectable antipsychotics with oral antipsychotics and hospital readmission rates in pediatric patients
by: Danial Chowdhury, PharmD, et al.
Published: (2024)

Severe olanzapine-induced liver function test elevation
by: Ericka Crouse, PharmD, BCPP, BCGP, FASHP, FASCP, et al.
Published: (2023)

Impact of marketing to improve patient access to care and clinic utilization for clinical pharmacy specialists
by: Nora Bairagdar, PharmD, BCPS, et al.
Published: (2023)

Psychotropic stewardship: Advancing patient care
by: Haight Robert J. PharmD, BCPP, et al.
Published: (2023)

Pharmacist impact on medication reconciliation of behavioral health patients boarding in the emergency department
by: Mary Accomando, PharmD, BCPP, et al.
Published: (2022)

Impact of holding home stimulant(s) on agitation in a child and adolescent inpatient psychiatric population
by: Anupha M. Mathew, PharmD, BCPS, et al.
Published: (2023)

Precipitated withdrawal with kratom use following naltrexone administration
by: Jarka Courtney PharmD, BCPS, BCPP, et al.
Published: (2023)

Design and Implementation of Antidepressant Decision Making Aids
by: Beth DeJongh, Pharm.D., BCPS, et al.
Published: (2012)